Skip to main content
logo
XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
1.420
-0.140 (-8.97%)
At close: Oct 15, 2026, 4:00 PM EDT
1.370
-0.050 (-3.52%)
After-hours: Oct 15, 2026, 7:53 PM EDT

XORTX Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Selling, General & Admin
1.751.832.192.281.931.22
Research & Development
0.260.570.182.426.760.68
Amortization of Goodwill & Intangibles
0.020.030.030.070.020.01
Operating Expenses
2.132.542.624.969.242.31
Operating Income
-2.13-2.54-2.62-4.96-9.24-2.31
Interest Expense
------0
Interest & Investment Income
0.020.040.120.250.1-
Currency Exchange Gain (Loss)
-0.01-0-0.07-0.01-0-0.01
Other Non Operating Income (Expenses)
-1.61-0.15-0.752.551.420.75
EBT Excluding Unusual Items
-3.74-2.65-3.31-2.16-7.72-1.58
Asset Writedown
-0-0----
Pretax Income
-3.74-2.66-3.31-2.16-7.72-1.58
Net Income
-3.74-2.66-3.31-2.16-7.72-1.58
Net Income to Common
-3.74-2.66-3.31-2.16-7.72-1.58
Net Income Growth
------
Shares Outstanding (Basic)
111000
Shares Outstanding (Diluted)
111000
Shares Change
93.11%64.48%45.25%33.91%35.25%47.77%
EPS (Basic)
-2.83-2.81-5.76-5.44-26.08-7.22
EPS (Diluted)
-2.83-2.81-5.76-5.45-26.10-7.22
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
-5.1-2.77-3.68-6.59-8.19-4.8
Free Cash Flow Per Share
-3.85-2.92-6.39-16.62-27.66-21.94
EBITDA
-2.15-2.51-2.58-4.82-9.22-2.3
D&A For EBITDA
-0.010.030.040.140.020.01
EBIT
-2.13-2.54-2.62-4.96-9.24-2.31
SEC Filings: 10-K · 10-Q